We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Knockdown of ubiquitin-like modifier-activating enzyme 2 promotes apoptosis of clear cell renal cell carcinoma cells.
- Authors
Zhang, Guoxi; Zou, Junrong; Shi, Jinglin; Qian, Biao; Qiu, Kaiyang; Liu, Quanliang; Xie, Tianpeng; He, Zhihua; Xu, Hui; Liao, Yunfeng; Wu, Yuting; Li, Yanmin; Xiao, Guancheng; Yuan, Yuanhu; Xiao, Rihai; Wu, Gengqing; Zou, Xiaofeng
- Abstract
Small ubiquitin-related modifier (SUMO) proteins are involved in the development of tumors. Ubiquitin-like modifier-activating enzyme 2 (UBA2) is an important member of the SUMO modification system; however, its role in clear cell renal cell carcinoma (ccRCC) is unclear. Therefore, we investigated the expression and function of UBA2 in ccRCC. Both mRNA and protein expression levels of UBA2 were found to be higher in ccRCC than in normal renal tissues and significantly related to the tumor size, Fuhrman grade, and tumor stage. UBA2 knockdown inhibited ccRCC cell growth, promoted apoptosis in vitro and in vivo, and decreased the abundance of a p53 mutant, c-Myc, and key enzymes of the SUMO modification system. Meanwhile, overexpression of UBA2 had the opposite effects. Overexpression of the p53 mutant or c-Myc alleviated the effects of UBA2 knockdown on ccRCC cell proliferation and apoptosis. In conclusion, targeting UBA2 may have a therapeutic potential against ccRCC.
- Publication
Cell Death & Disease, 2021, Vol 12, Issue 11, p1
- ISSN
2041-4889
- Publication type
Article
- DOI
10.1038/s41419-021-04347-7